Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.139 | -16.4127996222 | 0.8469 | 0.8469 | 0.6109 | 570465 | 0.6981699 | CS |
4 | -0.2524 | -26.2834530876 | 0.9603 | 1.36 | 0.6109 | 695540 | 1.01556335 | CS |
12 | -0.9821 | -58.1124260355 | 1.69 | 1.7494 | 0.6109 | 899077 | 1.16104086 | CS |
26 | -7.1921 | -91.0392405063 | 7.9 | 8.98 | 0.6109 | 771165 | 2.22890957 | CS |
52 | -5.4221 | -88.4518760196 | 6.13 | 11.41 | 0.6109 | 493166 | 3.18143794 | CS |
156 | -8.4021 | -92.2294182217 | 9.11 | 11.41 | 0.6109 | 384067 | 4.24253263 | CS |
260 | -14.7321 | -95.4151554404 | 15.44 | 18.42 | 0.6109 | 270727 | 5.27339364 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.